Примери за използване на Different process на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Clinical data with an AS03-containing vaccine containing HA from H1N1v manufactured using a different process suggest that a single dose may be sufficient.
two doses of an AS03-containing vaccine containing HA from H1N1v manufactured using a different process.
Clinical studies in healthy subjects who received two doses of an AS03-containing vaccine containing HA from H5N1 manufactured using a different process.
Immunogenicity data obtained at three weeks after administration of an AS03-containing vaccine containing HA from H1N1v manufactured using a different process in clinical studies suggest that a single dose may be sufficient.
manufactured using a different process Paediatric population.
These days we have more than 30 cryptocurrency debit cards in circulation with some differs between them of course such as different fee structures, different process of transactions between two cryptocurrencies, etc.
with an AS03-containing vaccine containing HA from H1N1v manufactured using a different process in children aged less than 6 months.
no information on administration of the AS03-containing vaccine containing HA from H1N1v manufactured using a different process with any other vaccines than non-adjuvanted seasonal influenza vaccine.
an AS03-containing vaccine containing HA from H1N1v manufactured using a different process(N=167).
dose of an AS03-containing vaccine containing HA from H1N1 manufactured using a different process in children aged 3 to 9 years.
Additional data on reactogenicity are available from clinical studies in healthy subjects of various age groups from 6 months of age upwards who received an AS03-containing vaccine containing HA from H1N1v manufactured using a different process.
Immunogenicity data obtained at three weeks after administration of an AS03-containing vaccine containing HA from H1N1v manufactured using a different process in clinical studies suggest that dosing may be in accordance with the recommendations for adults.
dose of an AS03-containing vaccine containing HA from H1N1 manufactured using a different process.
Preliminary immunogenicity data obtained with an AS03-containing vaccine containing HA from H1N1v manufactured using a different process in a limited number of children aged 6-35 months show that there is a further immune response to a second dose of 0.25 ml administered after an interval of three weeks.
Data obtained on co-administration of an AS03-containing vaccine containing HA from H1N1v manufactured using a different process with non-adjuvanted seasonal influenza vaccine(Fluarix,
an AS03-containing vaccine containing HA from H1N1v manufactured using a different process(N=167), the anti-HA antibody responses 21 days after a first dose were as follows.
three weeks before a dose of an AS03-containing vaccine containing HA from H1N1v manufactured using a different process in healthy adults over 60 years of age,
ml doses(21 days apart) of an AS03-containing vaccine containing HA from H1N1v manufactured using a different process, there was no increase in reactogenicity after the second dose compared to the first dose.
Very limited data with an AS03-containing vaccine containing HA from H1N1v manufactured using a different process in children aged 6 to 35 months(N=51)
There are limited data available from a clinical study with an AS03containing vaccine containing HA from H1N1v manufactured using a different process in healthy children aged from 10 to 17 years, very limited data with the AS03-containing vaccine containing HA from H1N1v manufactured using a different process in healthy children aged from 6 to 35 months and limited data from a study with a version of an AS03-containing vaccine containing HA from H5N1 manufactured using a different process in children aged from 3 to 9 years.